Kather Consulting
Biomedical AI Due Diligence & Advisory
Independent scientific and technical advisory
Kather Consulting & Holding GmbH advises investors, biotechnology companies and technology companies on artificial intelligence in biomedicine. Its principal area of expertise is AI in healthcare and biomedical research.
Advisory work concerns the scientific validity, technical feasibility and clinical development of biomedical AI systems. It is intended for organizations evaluating technologies, research programs or investment opportunities rather than for individual patients.
Scope of advisory work
- Scientific and technical due diligence for investors
- Assessment of biomedical AI technologies and evidence
- Evaluation of validation strategies and clinical feasibility
- AI research and development strategy
- Organizational readiness for biomedical AI
Areas of expertise
Relevant fields include computational pathology, AI-based biomarkers, multimodal AI, foundation models, clinical AI agents, clinical validation and privacy-preserving distributed machine learning. Assessments are based on the available scientific evidence, data, methods and intended clinical context.
Leadership
The company is led by Prof. Dr. med. Jakob Nikolas Kather, MSc, a physician and computer scientist working in clinical artificial intelligence and oncology. His academic profile, publications and approved biographies are maintained at kather.ai; information about the academic research group is available on the Kather Lab website.
Independence and scope
Kather Consulting does not provide medical treatment or individual patient advice. Services are provided independently of academic and clinical duties. The company does not use employer resources, and its activities do not represent or imply endorsement by a university, university hospital or other primary employer.